UBS Group AG - EYEPOINT PHARMACEUTICALS INC ownership

EYEPOINT PHARMACEUTICALS INC's ticker is EYPT and the CUSIP is 30233G100. A total of 35 filers reported holding EYEPOINT PHARMACEUTICALS INC in Q2 2018. The put-call ratio across all filers is 2.16 and the average weighting 0.0%.

Quarter-by-quarter ownership
UBS Group AG ownership history of EYEPOINT PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2020$72,000
-11.1%
137,627
+29.4%
0.00%
Q2 2020$81,000
+131.4%
106,375
+208.9%
0.00%
Q1 2020$35,000
-74.1%
34,432
-60.5%
0.00%
Q4 2019$135,000
+104.5%
87,219
+138.4%
0.00%
Q3 2019$66,000
+500.0%
36,582
+472.8%
0.00%
Q2 2019$11,000
-86.4%
6,386
-85.9%
0.00%
Q1 2019$81,000
-19.8%
45,200
-15.3%
0.00%
Q4 2018$101,000
-34.0%
53,351
+24.7%
0.00%
Q3 2018$153,000
+61.1%
42,789
-7.0%
0.00%
Q2 2018$95,00046,0100.00%
Other shareholders
EYEPOINT PHARMACEUTICALS INC shareholders Q2 2018
NameSharesValueWeighting ↓
Essex Woodlands Management, Inc. 41,909,219$21,793,00011.58%
Kore Private Wealth LLC 202,366$105,0000.02%
BARD ASSOCIATES INC 335,750$175,0000.02%
HighTower Advisors, LLC 5,284,688$2,738,0000.01%
GSA CAPITAL PARTNERS LLP 126,529$66,0000.01%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 654,200$339,0000.01%
Virtu Financial LLC 57,076$30,0000.01%
WEDBUSH SECURITIES INC 81,500$42,0000.00%
NEXPOINT ASSET MANAGEMENT, L.P. 33,933$18,0000.00%
MATRIX ASSET ADVISORS INC/NY 39,500$20,0000.00%
View complete list of EYEPOINT PHARMACEUTICALS INC shareholders